Proteins such as orosomucoid-1 (ORM1) and ceruloplasmin have been identified as potential biomarkers capable of distinguishing mild steatosis from healthy individuals and differentiating severe steatosis from mild cases in MASLD patients [36]. This evidence concerns the gene ORM1 and metabolic dysfunction-associated steatotic liver disease.